SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-18-073888
Filing Date
2018-03-07
Accepted
2018-03-07 20:58:32
Documents
5
Effectiveness Date
2018-03-07

Document Format Files

Seq Description Document Type Size
1 S-1MEF d503371ds1mef.htm S-1MEF 36549
2 EX-5.1 d503371dex51.htm EX-5.1 8001
3 EX-23.1 d503371dex231.htm EX-23.1 1379
4 GRAPHIC g503371g30i16.jpg GRAPHIC 10166
5 GRAPHIC g503371g50m32.jpg GRAPHIC 12831
  Complete submission text file 0001193125-18-073888.txt   79050
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-223512 | Film No.: 18674861
SIC: 2834 Pharmaceutical Preparations